Evidence map›Paper›PMID 36829182›Full record

ArticleJournal of neuroinflammation2023

Depletion and activation of microglia impact metabolic connectivity of the mouse brain.

Johannes Gnörich, Anika Reifschneider, Karin Wind, Artem Zatcepin, Sebastian T Kunte, Philipp Beumers, Laura M Bartos, Thomas Wiedemann, Maximilian Grosch, Xianyuan Xiang and 21 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07364162 (Exogenous Ketone Ester Supplementation in ICU Delirium), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07364162 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Exogenous Ketone Ester Supplementation in ICU Delirium (KETONES ICU)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2026 to 2027Enrolled40ConditionsICU Delirium, Critical IllnessArmsKetone monoester, Placebo
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Systematic review ofFrontiers in aging neuroscience · 2023
    Pooled it
  2. Article
  3. Article
  4. Assessment of early-phase [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 3 institutions in 2 countries.

Johannes GnörichDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Anika ReifschneiderMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
Karin WindDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Artem ZatcepinDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Sebastian T KunteDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Philipp BeumersDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Laura M BartosDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Thomas WiedemannMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
Maximilian GroschGerman Center for Vertigo and Balance Disorders, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Xianyuan XiangMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
Maryam K FardGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Francois RuchDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Georg WernerMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
Mara KoehlerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Luna SlemannDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Selina HummelDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Nils BrielGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Tanja BlumeGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Yuan ShiGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Gloria BiecheleDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Leonie BeyerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Florian EckenweberDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Maximilian ScheifeleDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Nathalie L AlbertDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Jochen HermsGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Sabina TahirovicGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Christian HaassGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Anja CapellMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
Sibylle ZieglerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany. Matthias.Brendel@med.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DEGerman Center for Neurodegenerative Diseases · DEMunich Cluster for Systems Neurology · DE

Funding

Alzheimer Forschung Initiative e.V. 18014Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy 390857198Koselleck Project HA1737/16-1
6 · The paper itself

Abstract

aimWe aimed to investigate the impact of microglial activity and microglial FDG uptake on metabolic connectivity, since microglial activation states determine FDG-PET alterations. Metabolic connectivity refers to a concept of interacting metabolic brain regions and receives growing interest in approaching complex cerebral metabolic networks in neurodegenerative diseases. However, underlying sources of metabolic connectivity remain to be elucidated. MATERIALS AND

methodsWe analyzed metabolic networks measured by interregional correlation coefficients (ICCs) of FDG-PET scans in WT mice and in mice with mutations in progranulin (Grn) or triggering receptor expressed on myeloid cells 2 (Trem2) knockouts (

resultsMicroglia depletion by CSF1R inhibition resulted in a strong decrease of metabolic connectivity defined by decrease of mean cortical ICCs in WT mice at both ages studied (6-7 m; p = 0.0148, 9-10 m; p = 0.0191), when compared to vehicle-treated age-matched WT mice. Grn

conclusionsPresence, absence, and activation of microglia have a strong impact on metabolic connectivity of the mouse brain. Enhanced metabolic connectivity is associated with increased microglial FDG allocation.

Indexed as

Fluorodeoxyglucose F18MicrogliaAnimalsBrainMembrane GlycoproteinsMicePositron-Emission TomographyProgranulinsReceptors, ImmunologicFluorodeoxyglucose F18Membrane GlycoproteinsProgranulinsReceptors, ImmunologicTrem2 protein, mouseFDG–PETMetabolic connectivityMicrogliaNeurodegenerationscRadiotracing

Identifiers

PMID36829182
PMCPMC9951492
OpenAlexW4321788757

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.